DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

company name or ticker

Morning Market Losers

Benzinga's Top #PreMarket Losers

Gilead Sciences Buying Achillion Was Twitter Speculation at its Finest

Momo, Take-Two, Urban Outfitters Lead Monday's After-Hours Movers

Why Achillion Pharmaceuticals, Inc. Shares Soared Today

Achillion Pharmaceuticals shares are heading higher on hopes that a suitor may emerge.

Monday's ETF Movers: PBE, ILF

Analyst Issues 5 Potential Biotech Buyout Candidates

Why Can't Gilead Run?

Dubious IP Makes Achillion Pharma A Stock To Avoid

Achillion Looks Less Risky After First-Quarter Earnings Beat

See More Articles...